Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.84 is 88% below its 5-year average of 14.91, near the low end of its 5-year range (1.84–35.15).
As of the fiscal period ended Tuesday, June 30, 2026. 68.83% below its 12-month average of 5.90.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.84.
CURRENT RATIO
1.84
CURRENT RATIO AVG TTM
5.90
CURRENT RATIO AVG 3Y
9.11
CURRENT RATIO AVG 5Y
14.91
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-68.83%
CURRENT VS 3Y AVG
-79.81%
CURRENT VS 5Y AVG
-87.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.74
median of 852 covered companies
CURRENT VS SECTOR MEDIAN
-50.76%
vs the sector median at left
Pulsenmore Ltd. Ordinary Shares
Market Cap
$14.14M
Current Ratio
1.84
TTM Avg
5.90
3Y Avg
9.11
5Y Avg
14.91
Market Cap
$13.92M
Current Ratio
2.36
TTM Avg
1.96
3Y Avg
1.68
5Y Avg
3.63
Market Cap
$13.50M
Current Ratio
0.84
TTM Avg
0.51
3Y Avg
4.20
5Y Avg
6.42
Market Cap
$14.79M
Current Ratio
26.25
TTM Avg
8.96
3Y Avg
10.61
5Y Avg
33.19
Market Cap
$15.24M
Current Ratio
1.24
TTM Avg
4.22
3Y Avg
12.60
5Y Avg
18.98
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $14.14M | 1.84 | 5.90 | 9.11 | 14.91 |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.11M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.93M | 4.37 | 1.46 | 1.74 | 1.95 |
| Sintx Technologies, Inc. (SINT)vs › | $13.92M | 2.36 | 1.96 | 1.68 | 3.63 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.50M | 0.84 | 0.51 | 4.20 | 6.42 |
| Optimi Health Corp. (OPTH)vs › | $13.51M | 1.73 | 0.30 | 1.36 | 3.00 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.79M | 26.25 | 8.96 | 10.61 | 33.19 |
| IN8bio, Inc. (INAB)vs › | $13.14M | 8.21 | 6.45 | 5.32 | 7.60 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | 1.24 | 4.22 | 12.60 | 18.98 |
| Passage Bio, Inc. (PASG)vs › | $12.95M | 1.22 | 3.07 | 6.03 | 8.35 |
Current Ratio
1.84
Quick Ratio
1.69
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.84 |
| 2025-12-31 | 7.88 |
| 2025-06-30 | 7.98 |
| 2024-12-31 | 9.28 |
| 2024-06-30 | 12.82 |
| 2023-12-31 | 11.65 |
| 2023-06-30 | 12.30 |
| 2022-12-31 | 13.61 |
| 2022-06-30 | 35.15 |
| 2021-12-31 | 24.64 |
| 2021-06-30 | 26.85 |
